In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. by Latini, Giuseppe et al.
Phthalate esters are used widely as plasticizers
for polyvinylchloride (PVC) formulations
in several applications, including medical
devices, toys, food wraps, and building prod-
ucts, to impart ﬂexibility to an otherwise rigid
PVC. Di-(2-ethylhexyl)phthalate (DEHP) is
the most commonly used plasticizer. Because
DEHP does not bind with the plastic, it
leaches with time and use from vinyl prod-
ucts, thus becoming a ubiquitous environ-
mental contaminant (Bauer and Herrmann
1997; Bradbury 1996; Giam et al. 1978;
Grifﬁths et al. 1985; Mayer et al. 1972; Mes
et al. 1974; Øie et al. 1997; Sharman et al.
1994). In particular, leaching of DEHP from
PVC medical devices and deposits in tissue
have been well documented (Latini 2000;
Tickner et al. 2001). Because the DEHP
action depends on dose, time, and age (Latini
2000) and because DEHP effects are influ-
enced by the stage of development at expo-
sure among animals (Akingbemi et al. 2001),
the DEHP-related exposure risk is potentially
higher for the developing fetus and newborn,
particularly preterm. Recently, our prelimi-
nary findings indicated that the exposure to
these environmental contaminants begins
during intrauterine life, that these chemicals
are able to cross the placental barrier, and that
fetal exposure is closely related to maternal
exposure (Latini et al. 2003). The aim of this
study was to measure concentrations of DEHP
and/or its main metabolite, mono-(2-ethyl-
hexyl)phthalate (MEHP), in a larger popu-
lation of human neonates and to evaluate
possible biologic effects from prenatal exposure
to DEHP and/or MEHP.
Patients and Methods
Subjects. Cord blood samples were collected
from 84 consecutive newborns (82 singletons,
two twins), born at the general-practice
Brindisi Hospital, with the following charac-
teristics: 39 male, 45 female; maternal age at
delivery, 29.5 ± 5.1 years (range = 18–42);
vaginal delivery, n = 65 (77.4%); gestational
age, 38.4 ± 2.2 weeks (range = 27–42); birth
weight, 3,220 ± 680 g, (range = 1,150–4,350);
1-min Apgar score, 7.9 ± 0.9; 5-min Apgar
score, 8.8 ± 0.5. Eleven of 84 infants were
preterm; only three had very low birth weight.
Moreover, four infants who were small for ges-
tational age (SGA) were present in our popula-
tion. None of the examined infants was born
after in vitro fertilization pregnancy. The study
was approved by the ethics committee of
the Brindisi Hospital (Brindisi, Italy), and
written informed consent from the parents
was obtained. Blood specimens were immedi-
ately centrifuged (3,500 × g, 7 min), and
serum was stored at –20°C until assay. To
avoid any contamination from plasticizers in
lab equipment, the serum sample collection,
preservation, and treatment were performed
only with glass devices. The concentrations of
DEHP and MEHP were determined by high-
performance liquid chromatography, at the
Department of Chemistry of the University
of L’Aquila, an institution certiﬁed in agree-
ment with the International Organization
for Standardization 9001 quality system, as
described previously (Paris et al. 2003).
Data analysis. Data are expressed as mean
± SD. Pairwise differences between groups were
assessed using either Fisher’s exact test (categor-
ical variables) or unpaired t-tests (continuous
variables). The relation between presence of
phthalates in the cord blood and potential pre-
natal risk factors was evaluated using univariate
analysis (MedCalc for Windows, version 7.0;
MedCalc Software, Mariakerke, Belgium). The
effects of potential confounders on the presence
of DEHP/MEHP in the cord blood were also
examined by using multivariable logistic regres-
sion models (SPSS release 6.1 statistical pack-
age; SPSS Inc., Chicago, IL, USA). Factors
with p-values < 0.25 at univariate analysis were
included in the multivariable logistic regression
models. The p-values were assessed by using
pairwise comparisons of each end point with
explanatory variables, excluding the others. A
two-sided p-value < 0.05 was considered statis-
tically signiﬁcant, and the Bonferroni-corrected
signiﬁcance levels were used for multiple t-tests.
Results
DEHP, MEHP, or both were present in 74 of
84 (88.1%) of the examined cord serum sam-
ples. DEHP and MEHP were each present in
65 of 84 (77.4%) of the examined samples.
Mean concentrations of DEHP and MEHP
were 1.19 ± 1.15 µg/mL [95% confidence
interval (CI), 0.93–1.44, range = 0–4.71] and
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Di-(2-ethylhexyl)phthalate (DEHP), the most commonly used plasticizer in flexible polyvinyl-
chloride formulations, is a ubiquitous environmental contaminant. To date, no information exists on
the potential health hazards from exposure to DEHP and/or its main metabolite, mono-(2-ethyl-
hexyl)phthalate (MEHP), in high-risk conditions, such as pregnancy and during the neonatal period.
The aim of this study was to evaluate prenatal exposure to DEHP and/or MEHP and its possible
biologic effects. We measured serum DEHP and MEHP concentrations in the cord blood of 84 con-
secutive newborns by high-performance liquid chromatography. Relationships between
DEHP/MEHP and infant characteristics were tested using Fisher’s exact test, unpaired t-tests, and
univariate linear regression analyses, and signiﬁcant differences on univariate analysis were evaluated
using multiple logistic regression analysis. We found detectable cord blood DEHP and/or MEHP
concentrations in 88.1% of the samples. Either DEHP or MEHP was present in 65 of 84 (77.4%)
of the examined samples. Mean concentrations of DEHP and MEHP were 1.19 ± 1.15 µg/mL [95%
conﬁdence interval (CI), 0.93–1.44, range = 0–4.71] and 0.52 ± 0.61 µg/mL (95% CI, 0.39–0.66,
range = 0–2.94), respectively. MEHP-positive newborns showed a signiﬁcantly lower gestational age
compared with MEHP-negative infants (p = 0.033). Logistic regression analysis results indicated a
positive correlation between absence of MEHP in cord blood and gestational age at delivery (odds
ratio = 1.50, 95% CI, 1.013–2.21; p = 0.043). These findings confirm that human exposure to
DEHP can begin in utero and suggest that phthalate exposure is signiﬁcantly associated with a shorter
pregnancy duration. Key words: di-(2-ethylhexyl)phthalate, environmental hazards, gestational age,
mono-(2-ethylhexyl)phthalate, prenatal exposure. Environ Health Perspect 111:1783–1785 (2003).
doi:10.1289/ehp.6202 available via http://dx.doi.org/ [Online 18 August 2003]
Children’s Health | Article0.52 ± 0.61 µg/mL (95% CI, 0.39–0.66,
range = 0–2.94), respectively. MEHP-positive
newborns showed a signiﬁcantly lower gesta-
tional age compared with MEHP-negative
infants (38.16 ± 2.34 vs. 39.35 ± 1.35; t =
–2.163, df = 81, p = 0.033; Figure 1). A com-
parison of gestational age in different phtha-
late categories is also shown in Tables 1 and 2
and Figure 2. The results of the logistic regres-
sion analysis indicated a positive correlation
between absence of MEHP in cord blood and
gestational age at delivery [fitted equation:
logit(p) = –16.98 + 0.40 × gestational age;
overall model ﬁt: chi-squared = 5.45, df = 1, p =
0.019; odds ratio = 1.50, 95% CI, 1.013–2.21].
No statistically significant relations were
observed between DEHP or MEHP concentra-
tions and sex of infant, delivery mode, maternal
smoking, premature rupture of the membranes,
presence of cord loops, neonatal jaundice, or
small size for gestational age (< 10th percentile
for sex and parity) (p ≥ 0.12). Furthermore, no
significant relations were observed between
DEHP or MEHP and birth weight, 1-min or
5-min Apgar scores, or maternal age (p ≥ 0.32).
Discussion
Our ﬁndings conﬁrm the presence of detectable
DEHP/MEHP in most of the examined new-
borns at birth, observe phthalate serum con-
centrations in a wide population of human
newborns, and suggest that phthalate exposure
is signiﬁcantly associated with a shorter preg-
nancy duration. Although the clinical relevance
of the observed statistical association deserves
further elucidation, this link appears to be plau-
sible, because a) exposure to environmental
contaminants other than DEHP has been asso-
ciated with decreased gestation length (Loch-
Caruso 2002; Tsai et al. 1997), and b) several
lines of evidence suggest a possible role for
DEHP in the induction and/or potentiation of
an intrauterine inﬂammatory response. A signif-
icant ring structure similarity has been observed
between DEHP and prostaglandins/trombox-
anes, which are proinflammatory mediators
(Maroziene and Grazuleviciene 2002); evidence
of DEHP-induced interleukin-1 secretion has
been reported in mononuclear cells (Calo et al.
1993); and both infants born to mothers with
prenatal infection/inﬂammation (De Felice et al.
1999, 2002) and DEHP-treated experimental
animals (Yang et al. 2000) have been reported to
undergo a surprisingly similar process of acute
thymic involution. Considering that intrauter-
ine infection/inﬂammation is a well-established
risk factor for prematurity (Goncalves et al.
2002), our observation of a shorter pregnancy
duration in prenatally exposed newborns sug-
gests that phthalates may play a role in inducing
an intrauterine inﬂammatory process. In addi-
tion, no statistically signiﬁcant differences in
other maternal and/or fetal factors potentially
affecting pregnancy duration were present in
our population.
The potential toxic effects of the observed
prenatal exposure to phthalates in human
newborns remain unknown to date. However,
DEHP-induced anti-androgenic action and
abnormalities of the male reproductive system
and in sexual behavior have been reported in
prenatally exposed animals, likely affecting
the normal development of the testes (Arcadi
et al. 1998; Foster et al. 2001; Gray et al.
2000; Moore et al. 2001; Tandon et al. 1991).
Moreover, DEHP effects on Leydig cell
steroidogenesis are inﬂuenced by the stage of
development at exposure among animals
(Akingbemi et al. 2001). The reproductive
toxicity mechanism of DEHP may be caused
by DEHP’s effects on steroid hormone metab-
olism and sexual development. In fact,
recently it has been demonstrated that DEHP
altered the expression of genes associated with
testis development and steroid hormone syn-
thesis (Wong and Gill 2002). Thus, although
the potential adverse effect of prenatal expo-
sure to DEHP on the male reproductive sys-
tem in humans needs to be investigated in
future studies, there is concern that DEHP is a
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Figure 1. Dot plots of comparisons of gestational age
(GA) between MEHP-positive and -negative infants.
MEHP = 1, MEHP-positive cord serum samples;
MEHP = 0, MEHP-negative cord serum samples.
42
40
38
36
34
32
30
28
26
MEHP = 1 MEHP = 0
■
■
■■■■ ■■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■
■■■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■
■
■■■■■■■■■■■■■
■ ■ ■ ■ ■ ■
■ ■ ■ ■
■ ■ ■ ■
■
■ ■
■ ■ ■ ■ ■ ■ ■
■
■ ■
■ ■
■ ■ ■ ■
■ ■ ■
G
A
 
(
w
e
e
k
s
)
Figure 2. Dot plots of comparisons of gestational
age (GA, in weeks) between different phthalate cat-
egories: 1, DEHP-negative, MEHP-negative infants;
2, DEHP-negative, MEHP-positive infants; 3, DEHP-
positive, MEHP-negative infants; 4, DEHP-positive,
MEHP-positive infants.
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Table 1. Associations between phthalate presence/absence and birth outcomes for n = 84 infants (range in parentheses).
Infants’ characteristics DEHP+/MEHP– DEHP+/MEHP+ DEHP–/MEHP+ DEHP–/MEHP–
Mean birth weight (g) 3411.11 ± 597.27 3,173 ± 706.01 3008.89 ± 602.7 3,533 ± 563.44
(2,550–4,350) (1,150–4,100) (1,950–3,700) (3,550–4,350)
Mean gestational age (weeks) 39 ± 1.32 38.27 ± 2.45 37.44 ± 1.59 39.60 ± 1.43
(37–41) (27–42) (35–40) (37–42)
Full-term infants (n = 73) AGA 9 48 6 10
SGA — — — —
Preterm infants ≤ 1,500 g (n = 3) AGA — 1 — —
SGA — 2 — —
Preterm infants > 1,500 g (n = 8) AGA — 5 1 —
SGA — — 2 —
Total (n)9 5 6 9 1 0
Abbreviations: AGA, adequate for gestational age; –, negative; +, positive; SGA, small for gestational age. 
Table 2. DEHP- and/or MEHP-positive versus -negative infants: comparisons between groups (range in parentheses).
Infants’ characteristics DEHP+ DEHP– p-Value MEHP+ MEHP– p-Value
Mean birth weight (g) 3206.15 ± 692.68 3284.74 ± 626.50 NS 3,150 ± 690.68 3475.26 ± 566.74 NS
(1,150–4,350) (1,950–4,350) (1,150–4,100) (2,550–4,350)
Mean gestational age (weeks) 38.37 ± 2.33 38.58 ± 1.84 NS 38.16 ± 2.34 39.35 ± 1.35 0.033
(27–42) (35–42) (27–42) (37–42)
Total 65 19 65 19
Abbreviations: –, negative; NS, not signiﬁcant; +, positive.human reproductive developmental toxicant.
In accordance with a recent report by the
Center for Devices and Radiological Health,
U.S. Food and Drug Administration, neonates
in neonatal intensive care units constitute a
population at particularly increased toxicity
risk because of multiple medical device–related
DEHP exposure (Center for Devices and
Radiological Health 2001; Hillman et al.
1975; Latini 2000; Latini and Avery 1999;
Loff et al. 2000; Plonait et al. 1993; Tickner et
al. 2001). Thus, it is conceivable that prenatal
and postnatal exposures may have synergistic
and cumulative actions in producing adverse
neonatal effects, especially for premature infants
with very low birth weight (Roth et al. 1988).
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